What is Tango Therapeutics's AOCI?

Tango Therapeutics (TNGX) reported AOCI of -$115K in Q1 2026.

How has Tango Therapeutics's AOCI changed year-over-year?

Tango Therapeutics's AOCI decreased by 159.3% year-over-year, from $194K to -$115K.

What is the long-term trend for Tango Therapeutics's AOCI?

Over 5 years (2020 to 2025), Tango Therapeutics's AOCI has grown at a 67.5% compound annual growth rate (CAGR), from $17K to $224K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Tango Therapeutics TNGX AOCI

AOCI at other companies

Bristol-Myers SquibbBMY

-$1.37B+3.8%

AmgenAMGN

-$190M+17.7%

Gilead SciencesGILD

$78M-15.2%

ExelixisEXEL

-$415K-121%

Cogent Biosciences, Inc.COGT

-$415K-353%

Lantheus HoldingsLNTH

-$1.87M-6.2%

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Enterprise value$4.43B+2,204%

P/S79.9×+74.4×

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's AOCI?: Tango Therapeutics (TNGX) reported AOCI of -$115K in Q1 2026.
How has Tango Therapeutics's AOCI changed year-over-year?: Tango Therapeutics's AOCI decreased by 159.3% year-over-year, from $194K to -$115K.
What is the long-term trend for Tango Therapeutics's AOCI?: Over 5 years (2020 to 2025), Tango Therapeutics's AOCI has grown at a 67.5% compound annual growth rate (CAGR), from $17K to $224K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.